Infectious Disease Unit - Internal Medicine Department, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain; Multidisciplinary COVID-Team, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain; Joint Commission for Infectious Disease Management, Control & Prevention, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain.
Infectious Disease Unit - Internal Medicine Department, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain; Multidisciplinary COVID-Team, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain; Joint Commission for Infectious Disease Management, Control & Prevention, Hospital de Barcelona, Societat Cooperativa d'Instal·lacions Assistencials Sanitàries (SCIAS), Barcelona, Spain.
Clin Microbiol Infect. 2021 Aug;27(8):1151-1157. doi: 10.1016/j.cmi.2021.04.002. Epub 2021 Apr 23.
Few data are available regarding follow up of patients with coronavirus disease 2019 (COVID-19) after their discharge. We aim to describe the long-term outcomes of survivors of hospitalization for COVID-19 followed up first at an outpatient facility and subsequently by telephone.
Observational prospective study conducted at a tertiary general hospital. Clinical and radiological progression was assessed and data were recorded on a standardized reporting form. Patients were divided into three groups according to Pao/Fio at hospitalization: Pao/Fio >300, Pao/Fio 300-200 and Pao/Fio <200. A logistic multivariate regression model was performed to identify factors associated with persistence of symptoms.
For facility follow up, 302 individuals were enrolled. Median follow up was 45 days after discharge; 78% (228/294) of patients had COVID-19-related symptoms (53% asthenia, 56% respiratory symptoms) and 40% (122/302) had residual pulmonary radiographic lesions. Pao/Fio <200 was an independent predictor of persistent dyspnoea (OR 1.87, 95% CI 1.38-2.52, p < 0.0001). Pao/Fio >300 was associated with resolution of chest radiographic lesions (OR 0.56, 95% CI 0.42-0.74, p < 0.0001). Fifty per cent of patients required specific medical follow up after the first consultation and were transferred to another physician. A total of 294 patients were contacted for telephone follow up after a median follow-up time of 7 months. Fifty per cent of patients (147/294) still presented symptoms and 49% (145/294) had psychological disorders. Asthenia was identified in 27% (78/294) and dyspnoea in 10% (28/294) of patients independently of Pao/Fio.
Patients with COVID-19 require long-term follow up because of the persistence of symptoms; patients with low Pao/Fio during the acute illness require special attention.
关于 2019 年冠状病毒病(COVID-19)患者出院后的随访,目前仅有少量数据。我们旨在描述在门诊设施进行首次随访,随后通过电话进行随访的 COVID-19 住院幸存者的长期结局。
在一家三级综合医院进行观察性前瞻性研究。评估临床和放射学进展,并在标准化报告表上记录数据。根据住院期间的 PaO2/FIO2 将患者分为三组:PaO2/FIO2>300、PaO2/FIO2 300-200 和 PaO2/FIO2<200。进行逻辑多元回归模型以确定与症状持续存在相关的因素。
对于设施随访,共纳入 302 人。出院后中位随访时间为 45 天;78%(228/294)的患者有 COVID-19 相关症状(53%乏力,56%呼吸系统症状),40%(302/122)有残留肺部放射影像学病变。PaO2/FIO2<200 是持续性呼吸困难的独立预测因素(OR 1.87,95%CI 1.38-2.52,p<0.0001)。PaO2/FIO2>300 与胸部放射影像学病变的消退相关(OR 0.56,95%CI 0.42-0.74,p<0.0001)。50%的患者在首次就诊后需要特定的医疗随访,并被转介给其他医生。在中位随访时间为 7 个月后,共联系了 294 名患者进行电话随访。50%的患者(147/294)仍有症状,49%(145/294)有心理障碍。乏力在 27%(78/294)的患者中独立于 PaO2/FIO2 存在,呼吸困难在 10%(28/294)的患者中独立于 PaO2/FIO2 存在。
由于症状持续存在,COVID-19 患者需要长期随访;急性疾病期间 PaO2/FIO2 较低的患者需要特别关注。